https://www.avient.com/sites/default/files/2021-04/versaflex-hc-bt218-biopharmaceutical-tubing-case-study.pdf
MEDICAL TUBING
EXTRUDER
B I O P H A R M A C E U T I C A L
T U B I N G
• Low leachables & extractables
• Great tensile performance and kink resistance
• Good thermal weldability
• Excellent clarity and medical blue tint
• ISO 10993-4 & 5, USP Class VI & Animal Derivative Free
(ADF)
• Supplied drop-in material replacement to
overcome supply constraints of incumbent TPE
• Offered a lower extractable profile than
comparable materials in the market
• Enabled easy material transition without changes
in tooling or thermal welding machine settings
• Formulated solution with proprietary additives to
provide clarity and prevent yellowing after
sterilization
Versaflex™ HC BT218 Thermoplastic
Elastomer
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-12/Avient_ProdStewardship_Policy_Dec_18_2023.pdf
Setting goals and objectives that drive continual improvement and
check effectiveness of risk reduction measures in product safety
and stewardship
https://www.avient.com/sites/default/files/2022-06/ISO_9001_2015_Cert_PolyOne.pdf
Certificate Of Conformance
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
https://www.avient.com/sites/default/files/2020-07/ISO 45001 14 March 2026.pdf
Certificate Of Conformance
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
https://www.avient.com/sites/default/files/2020-07/ISO 14001 - 14 March 2026.pdf
Certificate Of Conformance
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
https://www.avient.com/sites/default/files/resources/Ramos_ISO_14001.pdf
Gamma 650
Parque Industrial Santa María
Ramos Arizpe, Coahuila 25900
México
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
ISO 14001:2015
The Environment Management System is applicable to:
COMPOUNDING OF THERMOPLASTIC PRODUCTS
This certificate may be found on the ABS QE Website (www.abs-qe.com).
https://www.avient.com/sites/default/files/2024-12/ISO-14001_English_Shanghai Zhangjiang.pdf
MSC Certificate
Place and date: For the issuing office:
Shanghai, 20 March 2024 DNV - Business Assurance
Building 9, No. 1591 Hongqiao Road,
Changning DistrictShanghai China 200336
Zhu Hai Ming
Management Representative
Lack of fulfilment of conditions as set out in the Certification Agreement may render this Certificate invalid.
https://www.avient.com/sites/default/files/2025-03/ECCOH XL Cable Insulation Case Study Snapshot.pdf
POWER CABLE
PRODUCER
C A B L E I N S U L A T I O N
• Easy to process
• To pass CPR fire test
• Low smoke and toxicity values on smoke test
• Possibilities for low-voltage cables
• Cable insulation that passed G18 of the CEI EN 50363-0:
2015 standard
• Offered Sioplas technology for cross-linking
providing ambient curing
• Delivered new cable design possibilities for low-
voltage cables while offering easy processing
• Processed more efficiently than market-
established elastomeric technology which is
processed using a CV line
• Provided cable insulation that passes the hot set
test at 250°C
ECCOH XL Cross-Linkable Solutions 8054
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
A brief
description of the types of awards which may be granted under the 2017 Plan is set forff th below.
Our Board sets the appropriate “tone at the top” when it comes to risk tolerance and management.
The 2016 performance goals for our performance measures were set in accordance with our strategic plan
framework.
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement %28Filed%29.pdf
Our Board sets the appropriate “tone at the top” when it comes to risk tolerance and management.
The 2023 performance goals were set in accordance with our strategic plan
framework and annual operating plan, developed at the end of 2022.
The SARs granted in 2023 to the Named Executive Officers are set forth in the 2023 Grants of Plan-
Based Awards table of this proxy statement.